Search results
Samsung Biologics unveils $920 million manufacturing deals for Pfizer
Reuters via Yahoo Singapore Finance· 1 year agoSouth Korea's Samsung Biologics announced on Tuesday two deals with Pfizer worth around a combined...
Trending tickers: Apple | Samsung | GSK | Jupiter
Yahoo Finance UK· 7 months agoThe Apple Vision Pro will be available in US stores beginning 2 February. ASSOCIATED PRESS Apple (AAPL) Apple will release its new Vision Pro headset in...
Samsung chief Jay Y. Lee acquitted in 2015 merger case
TechCrunch via Yahoo News Singapore· 6 months agoSamsung Electronics executive chairman Jay Y. Lee has been declared not guilty on the charge of...
Samsung chief Lee Jae-yong is acquitted of financial crimes related to 2015 merger
Associated Press Finance via Yahoo Singapore Finance· 6 months agoA South Korean court on Monday acquitted Samsung Electronics Chairman Lee Jae-yong of financial...
The Top Country With Most Scientists per Capita in the World
Insider Monkey via Yahoo Singapore Finance· 1 month agoWe recently compiled a list of the 10 Countries With the Most Scientists per Capita in the World and...
Can Biogen (BIIB) Navigate Multiple Challenges & Grow Again?
Zacks via Yahoo Singapore Finance· 2 years agoMost of Biogen's (BIIB) key drugs are facing declining sales. Despite these challenges, we are...
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 5 months agoRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2023 Earnings Call Transcript March 1, 2024 Rapid...
Matthews Pacific Tiger Fund's Strategic Moves: Spotlight on Meituan's Significant Reduction
GuruFocus.com via Yahoo Singapore Finance· 6 months agoInsightful Analysis of Matthews Pacific Tiger Fund (Trades, Portfolio)'s Latest 13F Filing for Q4...
How AbbVie denied Americans access to fair competition for Humira
Quartz via Yahoo News Singapore· 2 years agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative...
Novartis' (NVS) Sandoz Gets EC Nod for Tysabri's Biosimilar
Zacks via Yahoo Singapore Finance· 10 months agoNovartis’ NVS generic arm Sandoz announced that the European Commission (EC) granted marketing...